MedTrace Logo

Collective Accuryn Physiologic Signals and Signatures

NCT03817281 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2021-01-13

No results posted yet for this study

Summary

The CAPSS Study is a retrospective and prospective, multi-center, single-arm post-market data collection study with an FDA cleared device. Physiologic data measurements will be collected from enrolled subjects using electronic health records and data streams via the Accuryn Monitoring System. Analysis of these data has the potential to be able to acutely guide resuscitation and monitor trends for emerging critical conditions.

Conditions

Interventions

DEVICE

Accuryn Monitoring System

The Accuryn Monitoring System is a novel Foley catheter and monitoring device capable of detecting physiologic changes in vital signs via sensors within the catheter system. These data are captured non-invasively, continuously, and at a high frequency.

Sponsors & Collaborators

  • Potrero Medical

    lead INDUSTRY

Principal Investigators

  • Eileen M Bulger, MD · University of Washington Harborview

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-03-29
Primary Completion
2020-03-29
Completion
2020-03-29
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03817281 on ClinicalTrials.gov